BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34973114)

  • 1. Usefulness of quantitative
    Ogasawara K; Shiraishi S; Tsuda N; Sakamoto F; Oda S; Takashio S; Tsujita K; Hirai T
    Jpn J Radiol; 2022 May; 40(5):508-517. PubMed ID: 34973114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transthyretin amyloid cardiomyopathy disease burden quantified using
    Watanabe S; Nakajima K; Toshima F; Wakabayashi H; Yoshida S; Yoneyama H; Komatsu J; Konishi T; Kinuya S
    J Nucl Cardiol; 2023 Dec; 30(6):2721-2735. PubMed ID: 37605060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era.
    Martyn T; Saef J; Hussain M; Ives L; Kiang A; Estep JD; Collier P; Starling RC; Cremer PC; Tang WHW; Hanna M; Jaber WA
    J Card Fail; 2022 Oct; 28(10):1509-1518. PubMed ID: 35843490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and
    Ochi Y; Kubo T; Nakashima Y; Baba Y; Hirota T; Yamasaki N; Yamashita T; Ueda M; Ando Y; Kitaoka H
    J Cardiol; 2020 Jan; 75(1):12-19. PubMed ID: 31324572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 1-h with 3-h planar
    Saitou T; Aikawa T; Manabe O; Nagase A; Kudo T; Oyama-Manabe N
    Ann Nucl Med; 2023 Feb; 37(2):99-107. PubMed ID: 36352186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive detection and differentiation of cardiac amyloidosis using
    Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
    Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volumetric evaluation of
    Watanabe S; Nakajima K; Wakabayashi H; Yoneyama H; Yoshida S; Komatsu J; Konishi T; Inaki A; Kinuya S
    J Nucl Cardiol; 2022 Dec; 29(6):3102-3110. PubMed ID: 34907500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Commonly Examined Parameters Is a Useful Predictor of Positive
    Marume K; Takashio S; Nishi M; Hirakawa K; Yamamoto M; Hanatani S; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Sakamoto K; Yamamoto E; Kaikita K; Izumiya Y; Yamashita Y; Ando Y; Tsujita K
    Circ J; 2019 Jul; 83(8):1698-1708. PubMed ID: 31189791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
    Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
    [No Abstract]   [Full Text] [Related]  

  • 10. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
    Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
    JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.
    Cuddy SA; Datar Y; Ovsak G; Saith S; Murphy SP; Bay CP; Haddad M; Lilleness B; Muralidhar V; Pipilas A; Vuong J; Guardino E; Maurer MS; Ruberg FL; Falk RH; Dorbala S
    Circ Cardiovasc Imaging; 2022 Nov; 15(11):e014645. PubMed ID: 36378779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Kumamoto criteria for prediction of
    Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
    J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.
    Nagai T; Horinouchi H; Hashimoto K; Ichiji T; Yoshioka K; Hashimoto J; Ikari Y
    Echocardiography; 2023 Jul; 40(7):634-641. PubMed ID: 37243310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of relative apical longitudinal strain index to predict positive
    Usuku H; Takashio S; Yamamoto E; Kinoshita Y; Nishi M; Oike F; Marume K; Hirakawa K; Tabata N; Oda S; Misumi Y; Ueda M; Kawano H; Kaikita K; Matsushita K; Ando Y; Matsui H; Tsujita K
    Echocardiography; 2020 Nov; 37(11):1774-1783. PubMed ID: 33145817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study?
    Shen CP; Vanichsarn CT; Pandey AC; Billick K; Rubenson DS; Mohan RC; Heywood JT; Srivastava AV
    Int J Cardiovasc Imaging; 2023 Jan; 39(1):201-208. PubMed ID: 36598681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population.
    Bourque JM; Schepart A; Bhambri R; Castaño A; O'Brien A; Chen Y; Prasad S; Roy A; Grodin JL
    Am J Cardiol; 2022 Mar; 167():98-103. PubMed ID: 35022130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of
    Guo H; Wu S; Xiang X; Wang S; Fang Z; Ye Q; Zou Y; Wang Y; Peng D; Ma X
    Ann Nucl Med; 2024 Apr; 38(4):288-295. PubMed ID: 38252229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
    Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiographic indices of left ventricular function and filling pressure are not related to blood pool activity on pyrophosphate scintigraphy.
    Asif T; Gupta A; Murthi M; Soman P; Singh V; Malhotra S
    J Nucl Cardiol; 2023 Apr; 30(2):708-715. PubMed ID: 35578000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of Technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis.
    Miller RJH; Cadet S; Mah D; Pournazari P; Chan D; Fine NM; Berman DS; Slomka PJ
    J Nucl Cardiol; 2021 Oct; 28(5):1835-1845. PubMed ID: 33689152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.